Skip to main content
Top
Published in: AIDS and Behavior 8/2018

01-08-2018 | Original Paper

Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study

Authors: Roman Shrestha, Frederick L. Altice, Pramila Karki, Michael M. Copenhaver

Published in: AIDS and Behavior | Issue 8/2018

Login to get access

Abstract

This study reports the feasibility, acceptability, and preliminary efficacy of the bio-behavioral community-friendly health recovery program—an integrated, HIV prevention intervention to improve pre-exposure prophylaxis (PrEP) adherence and HIV-risk reduction behaviors among high-risk people who use drugs. We used a within-subjects, pretest–posttest follow-up design to recruit participants, who were HIV-uninfected, methadone-maintained and reported HIV-risk behaviors and had initiated PrEP (n = 40; males: 55%). Participants were assessed at baseline (T0), immediately post-intervention (4 weeks: T4) and 4 weeks post-intervention (T8). Immediately after completing the four weekly intervention groups, participants underwent a post-intervention assessment including in-depth qualitative interviews. Feasibility was high, assessed by participant willingness to enroll (90.1%) and retention (95%). Results showed that participants were highly satisfied and perceived the intervention as valuable and acceptable [mean: 81.3 (range 0–100)]. Significant enhancements in self-reported PrEP adherence [F(2,74) = 7.500, p = 0.001] and PrEP-related knowledge [F(2,74) = 3.828, p = 0.026] were observed. Drug-related (e.g., injection of drugs, sharing of injection equipment) and sex-related (e.g., number of sexual partners, condomless sex) risk behaviors were reduced, while information, motivation, and behavioral skills (IMB) constructs increased. The results support feasibility and high acceptability and support further examination of the efficacy of this combination bio-behavioral intervention in a prospective clinical trial.
Literature
2.
go back to reference Marshall BDL, Friedman SR, Monteiro JFG, Paczkowski M, Tempalski B, Pouget ER, et al. Prevention and treatment produced large decreases in HIV incidence in a model of people who inject drugs. Health Aff. 2014;33(3):401–9.CrossRef Marshall BDL, Friedman SR, Monteiro JFG, Paczkowski M, Tempalski B, Pouget ER, et al. Prevention and treatment produced large decreases in HIV incidence in a model of people who inject drugs. Health Aff. 2014;33(3):401–9.CrossRef
3.
go back to reference Noar SM. Behavioral interventions to reduce HIV-related sexual risk behavior: review and synthesis of meta-analytic evidence. AIDS Behav. 2008;12(3):335–53.CrossRefPubMed Noar SM. Behavioral interventions to reduce HIV-related sexual risk behavior: review and synthesis of meta-analytic evidence. AIDS Behav. 2008;12(3):335–53.CrossRefPubMed
4.
go back to reference Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268–84.CrossRefPubMed Strathdee SA, Hallett TB, Bobrova N, Rhodes T, Booth R, Abdool R, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376(9737):268–84.CrossRefPubMed
5.
go back to reference Volkow ND, Montaner J. The urgency of providing comprehensive and integrated treatment for substance abusers with HIV. Health Aff (Project Hope). 2011;30(8):1411–9.CrossRef Volkow ND, Montaner J. The urgency of providing comprehensive and integrated treatment for substance abusers with HIV. Health Aff (Project Hope). 2011;30(8):1411–9.CrossRef
6.
7.
go back to reference CDC. Effective interventions: HIV prevention that works. Atlanta: CDC; 2017. CDC. Effective interventions: HIV prevention that works. Atlanta: CDC; 2017.
8.
go back to reference Sadeghi-Najafabadi M. The influence of neurocognitive impairment on hiv risk reduction intervention outcomes among drug dependent methadone-maintained patients. Storrs: University of Connecticut; 2013. Sadeghi-Najafabadi M. The influence of neurocognitive impairment on hiv risk reduction intervention outcomes among drug dependent methadone-maintained patients. Storrs: University of Connecticut; 2013.
9.
go back to reference Worley MJ, Tate SR, Brown SA. Mediational relations between 12-step attendance, depression, and substance use in patients with comorbid substance dependence and major depression. Addiction. 2012;107(11):1974–83.CrossRefPubMedPubMedCentral Worley MJ, Tate SR, Brown SA. Mediational relations between 12-step attendance, depression, and substance use in patients with comorbid substance dependence and major depression. Addiction. 2012;107(11):1974–83.CrossRefPubMedPubMedCentral
10.
go back to reference Huedo-Medina TB, Shrestha R, Copenhaver M. Modeling a theory-based approach to examine the influence of neurocognitive impairment on HIV risk reduction behaviors among drug users in treatment. AIDS Behav. 2016;20(8):1646–57.CrossRefPubMedPubMedCentral Huedo-Medina TB, Shrestha R, Copenhaver M. Modeling a theory-based approach to examine the influence of neurocognitive impairment on HIV risk reduction behaviors among drug users in treatment. AIDS Behav. 2016;20(8):1646–57.CrossRefPubMedPubMedCentral
11.
go back to reference CDC. Preexposure prophylaxis for the prevention of HIV infection in the United States—2014: a clinical practice guideline. Washington, DC: Department of Health and Human Services USA—Centers for Disease Control and Prevention; 2014. CDC. Preexposure prophylaxis for the prevention of HIV infection in the United States—2014: a clinical practice guideline. Washington, DC: Department of Health and Human Services USA—Centers for Disease Control and Prevention; 2014.
12.
go back to reference Shrestha R, Karki P, Altice FL, Huedo-Medina TB, Meyer JP, Madden L, et al. Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment. Drug Alcohol Depend. 2017;173:107–16.CrossRefPubMedPubMedCentral Shrestha R, Karki P, Altice FL, Huedo-Medina TB, Meyer JP, Madden L, et al. Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment. Drug Alcohol Depend. 2017;173:107–16.CrossRefPubMedPubMedCentral
14.
go back to reference Kuo I, Olsen H, Patrick R, Phillips G II, Magnus M, Opoku J, et al. Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC. Drug Alcohol Depend. 2016;164:8–13.CrossRefPubMed Kuo I, Olsen H, Patrick R, Phillips G II, Magnus M, Opoku J, et al. Willingness to use HIV pre-exposure prophylaxis among community-recruited, older people who inject drugs in Washington, DC. Drug Alcohol Depend. 2016;164:8–13.CrossRefPubMed
16.
go back to reference Shrestha R, Altice F, Karki P, Copenhaver M. Developing an integrated, brief bio-behavioral HIV prevention intervention for high risk drug users in treatment: the process and outcome of formative research. Front Immunol. 2017;8:561.CrossRefPubMedPubMedCentral Shrestha R, Altice F, Karki P, Copenhaver M. Developing an integrated, brief bio-behavioral HIV prevention intervention for high risk drug users in treatment: the process and outcome of formative research. Front Immunol. 2017;8:561.CrossRefPubMedPubMedCentral
17.
go back to reference Brown G, Reeders D, Dowsett GW, Ellard J, Carman M, Hendry N, et al. Investigating combination HIV prevention: isolated interventions or complex system. J Int AIDS Soc. 2015;18(1):20499.CrossRefPubMedPubMedCentral Brown G, Reeders D, Dowsett GW, Ellard J, Carman M, Hendry N, et al. Investigating combination HIV prevention: isolated interventions or complex system. J Int AIDS Soc. 2015;18(1):20499.CrossRefPubMedPubMedCentral
18.
go back to reference Brown JL, Sales JM, DiClemente RJ. Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches. Curr HIV/AIDS Rep. 2014;11(4):363–75.CrossRefPubMedPubMedCentral Brown JL, Sales JM, DiClemente RJ. Combination HIV prevention interventions: the potential of integrated behavioral and biomedical approaches. Curr HIV/AIDS Rep. 2014;11(4):363–75.CrossRefPubMedPubMedCentral
19.
go back to reference Buchbinder SP, Liu A. Pre-exposure prophylaxis and the promise of combination prevention approaches. AIDS Behav. 2011;15(1):72–9.CrossRefPubMedCentral Buchbinder SP, Liu A. Pre-exposure prophylaxis and the promise of combination prevention approaches. AIDS Behav. 2011;15(1):72–9.CrossRefPubMedCentral
20.
go back to reference Meade CS, Towe SL, Skalski LM, Robertson KR. Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States. Drug Alcohol Depend. 2015;149:128–35.CrossRefPubMedPubMedCentral Meade CS, Towe SL, Skalski LM, Robertson KR. Independent effects of HIV infection and cocaine dependence on neurocognitive impairment in a community sample living in the southern United States. Drug Alcohol Depend. 2015;149:128–35.CrossRefPubMedPubMedCentral
21.
go back to reference Potvin S, Stavro K, Rizkallah E, Pelletier J. Cocaine and cognition: a systematic quantitative review. J Addict Med. 2014;8(5):368–76.CrossRefPubMed Potvin S, Stavro K, Rizkallah E, Pelletier J. Cocaine and cognition: a systematic quantitative review. J Addict Med. 2014;8(5):368–76.CrossRefPubMed
22.
go back to reference Anderson AM, Higgins MK, Ownby RL, Waldrop-Valverde D. Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence. AIDS Care. 2015;27(3):333–7.CrossRefPubMed Anderson AM, Higgins MK, Ownby RL, Waldrop-Valverde D. Changes in neurocognition and adherence over six months in HIV-infected individuals with cocaine or heroin dependence. AIDS Care. 2015;27(3):333–7.CrossRefPubMed
23.
go back to reference Shrestha R, Huedo-Medina T, Altice F, Krishnan A, Copenhaver M. Examining the acceptability of mHealth technology in HIV prevention among high-risk drug users in treatment. AIDS Behav. 2016;21:3100–10.CrossRef Shrestha R, Huedo-Medina T, Altice F, Krishnan A, Copenhaver M. Examining the acceptability of mHealth technology in HIV prevention among high-risk drug users in treatment. AIDS Behav. 2016;21:3100–10.CrossRef
24.
go back to reference Shrestha R, Huedo-Medina T, Copenhaver M. Sex-related differences in self-reported neurocognitive impairment among high-risk cocaine users in methadone maintenance treatment program. Subst Abuse Res Treat. 2015;9:17–24. Shrestha R, Huedo-Medina T, Copenhaver M. Sex-related differences in self-reported neurocognitive impairment among high-risk cocaine users in methadone maintenance treatment program. Subst Abuse Res Treat. 2015;9:17–24.
25.
go back to reference SAMHSA. National registry of evidence-based programs and practices (NREPP). Rockville: SAMHSA; 2015. SAMHSA. National registry of evidence-based programs and practices (NREPP). Rockville: SAMHSA; 2015.
27.
go back to reference Carroll KM, Nich C, Sifry RL, Nuro KF, Frankforter TL, Ball SA, et al. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend. 2000;57(3):225–38.CrossRefPubMed Carroll KM, Nich C, Sifry RL, Nuro KF, Frankforter TL, Ball SA, et al. A general system for evaluating therapist adherence and competence in psychotherapy research in the addictions. Drug Alcohol Depend. 2000;57(3):225–38.CrossRefPubMed
28.
go back to reference Tarnowski KJ, Simonian SJ. Assessing treatment acceptance: the abbreviated acceptability rating profile. J Behav Ther Exp Psychiatry. 1992;23(2):101–6.CrossRefPubMed Tarnowski KJ, Simonian SJ. Assessing treatment acceptance: the abbreviated acceptability rating profile. J Behav Ther Exp Psychiatry. 1992;23(2):101–6.CrossRefPubMed
29.
go back to reference Wilson IB, Lee Y, Michaud J, Fowler FJ, Rogers WH. Validation of a new three-item self-report measure for medication adherence. AIDS Behav. 2016;20(11):2700–8.CrossRefPubMedPubMedCentral Wilson IB, Lee Y, Michaud J, Fowler FJ, Rogers WH. Validation of a new three-item self-report measure for medication adherence. AIDS Behav. 2016;20(11):2700–8.CrossRefPubMedPubMedCentral
30.
go back to reference Dowling-Guyer S, Johnson ME, Fisher DG, Needle R, Watters J, Andersen M, et al. Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994;1(4):383–92.CrossRef Dowling-Guyer S, Johnson ME, Fisher DG, Needle R, Watters J, Andersen M, et al. Reliability of drug users’ self-reported HIV risk behaviors and validity of self-reported recent drug use. Assessment. 1994;1(4):383–92.CrossRef
32.
go back to reference Copenhaver M, Lee I, Baldwin P. A randomized controlled trial of the community-friendly health recovery program (CHRP) among high-risk drug users in treatment. AIDS Behav. 2013;17(9):2902–13.CrossRefPubMed Copenhaver M, Lee I, Baldwin P. A randomized controlled trial of the community-friendly health recovery program (CHRP) among high-risk drug users in treatment. AIDS Behav. 2013;17(9):2902–13.CrossRefPubMed
33.
go back to reference Avants SK, Margolin A, Usubiaga MH, Doebrick C. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy. J Subst Abuse Treat. 2004;26(2):67–78.CrossRefPubMed Avants SK, Margolin A, Usubiaga MH, Doebrick C. Targeting HIV-related outcomes with intravenous drug users maintained on methadone: a randomized clinical trial of a harm reduction group therapy. J Subst Abuse Treat. 2004;26(2):67–78.CrossRefPubMed
35.
go back to reference Liu A, Colfax G, Cohen S, Bacon O. The spectrum of engagement in HIV prevention: proposal for a pre-exposure prophylaxis (PrEP) cascade. In: 7th international conference on HIV treatment and prevention adherence, Miami, FL (2012). Liu A, Colfax G, Cohen S, Bacon O. The spectrum of engagement in HIV prevention: proposal for a pre-exposure prophylaxis (PrEP) cascade. In: 7th international conference on HIV treatment and prevention adherence, Miami, FL (2012).
36.
go back to reference Spector AY, Remien RH, Tross S. PrEP in substance abuse treatment: a qualitative study of treatment provider perspectives. Subst Abuse Treat Prev Policy. 2015;10(1):1–10.CrossRefPubMedPubMedCentral Spector AY, Remien RH, Tross S. PrEP in substance abuse treatment: a qualitative study of treatment provider perspectives. Subst Abuse Treat Prev Policy. 2015;10(1):1–10.CrossRefPubMedPubMedCentral
37.
go back to reference Siedner MJ, Haberer JE, Bwana MB, Ware NC, Bangsberg DR. High acceptability for cell phone text messages to improve communication of laboratory results with HIV-infected patients in rural Uganda: a cross-sectional survey study. BMC Med Inform Decis Mak. 2012;12:56.CrossRefPubMedPubMedCentral Siedner MJ, Haberer JE, Bwana MB, Ware NC, Bangsberg DR. High acceptability for cell phone text messages to improve communication of laboratory results with HIV-infected patients in rural Uganda: a cross-sectional survey study. BMC Med Inform Decis Mak. 2012;12:56.CrossRefPubMedPubMedCentral
38.
go back to reference Tolan PH, Gorman-Smith D, Henry D, Schoeny M. The benefits of booster interventions: evidence from a family-focused prevention program. Prev Sci. 2009;10(4):287–97.CrossRefPubMed Tolan PH, Gorman-Smith D, Henry D, Schoeny M. The benefits of booster interventions: evidence from a family-focused prevention program. Prev Sci. 2009;10(4):287–97.CrossRefPubMed
39.
go back to reference Liu A, Colfax G, Cohen S, Bacon O, Kolber M, Amico K, et al. The spectrum of engagement in HIV prevention: proposal for a PrEP cascade. In: 7th international conference on HIV treatment and prevention adherence, Miami Beach, FL (2012). Liu A, Colfax G, Cohen S, Bacon O, Kolber M, Amico K, et al. The spectrum of engagement in HIV prevention: proposal for a PrEP cascade. In: 7th international conference on HIV treatment and prevention adherence, Miami Beach, FL (2012).
Metadata
Title
Integrated Bio-behavioral Approach to Improve Adherence to Pre-exposure Prophylaxis and Reduce HIV Risk in People Who Use Drugs: A Pilot Feasibility Study
Authors
Roman Shrestha
Frederick L. Altice
Pramila Karki
Michael M. Copenhaver
Publication date
01-08-2018
Publisher
Springer US
Published in
AIDS and Behavior / Issue 8/2018
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-018-2099-0

Other articles of this Issue 8/2018

AIDS and Behavior 8/2018 Go to the issue